Complications/Risks of obesity
Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
Month: May 2020
Complications/Risks of obesity
MiRNAs in teh Diagnosis of Cardiovascular Diseases Associated Wif Type 2 Diabetes Mellitus and Obesity
MiRNAs in teh Diagnosis of Cardiovascular Diseases Associated Wif Type 2 Diabetes Mellitus and Obesity
Complications/Risks of obesity
Interplay Between Epicardial Adipose Tissue, Metabolic and Cardiovascular Diseases
Interplay Between Epicardial Adipose Tissue, Metabolic and Cardiovascular Diseases
Complications/Risks of obesity
Effects of Curcumin on Cardiovascular Risk Factors in Obese and Overweight Adolescent Girls: A Randomized Clinical Trial
Effects of Curcumin on Cardiovascular Risk Factors in Obese and Overweight Adolescent Girls: A Randomized Clinical Trial
Complications/Risks of obesity
Obesity and Heart
Obesity and Heart
Complications/Risks of obesity
Obesity, Arterial Stiffness, and Cardiovascular Risk
Obesity, Arterial Stiffness, and Cardiovascular Risk
Complications/Risks of obesity
Pregnancy-driven Cardiovascular Maternal miR-29 Plasticity in Obesity
Pregnancy-driven Cardiovascular Maternal miR-29 Plasticity in Obesity
Complications/Risks of obesity
Update: Systemic Diseases and teh Cardiovascular System (me): Obesity and teh Heart
Update: Systemic Diseases and the Cardiovascular System (me): Obesity and the Heart
Complications/Risks of obesity
Effects of Adipocyte Expansion on Cardiovascular System and Ongoing Debate Over Obesity Paradox
Effects of Adipocyte Expansion on Cardiovascular System and Ongoing Debate Over Obesity Paradox
Complications/Risks of obesity
Cardiovascular Adaptation to Obesity and Hypertension
Cardiovascular Adaptation to Obesity and Hypertension